Trial Details

COMPLETED
Basic Information
Clinical ID c2790
Identifier NCT02955316
Trial Title Irritable Bowel Syndrome Survey in Gastroenterological Adult Outpatients in China
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Irritable Bowel Syndrome (IBS)
Interventions -
Participant Information
Sponsor AstraZeneca
City Hubei
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2017-02-10
Primary Completion Date 2017-09-30
Completion Date 2017-09-30